These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26991731)

  • 1. Kinesin-1 inhibits the aggregation of amyloid-β peptide as detected by fluorescence cross-correlation spectroscopy.
    Zheng Y; Tian S; Peng X; Yang J; Fu Y; Jiao Y; Zhao J; He J; Hong T
    FEBS Lett; 2016 Apr; 590(7):1028-37. PubMed ID: 26991731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photo-induced inhibition of Alzheimer's β-amyloid aggregation in vitro by rose bengal.
    Lee JS; Lee BI; Park CB
    Biomaterials; 2015 Jan; 38():43-9. PubMed ID: 25457982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors.
    Krotee P; Griner SL; Sawaya MR; Cascio D; Rodriguez JA; Shi D; Philipp S; Murray K; Saelices L; Lee J; Seidler P; Glabe CG; Jiang L; Gonen T; Eisenberg DS
    J Biol Chem; 2018 Feb; 293(8):2888-2902. PubMed ID: 29282295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
    Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
    ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.
    Perlenfein TJ; Murphy RM
    J Biol Chem; 2017 Dec; 292(51):21071-21082. PubMed ID: 29046353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin inhibits Aβ
    Xu L; Tian S; Peng X; Hua Y; Yang W; Chen L; Liu S; Wu W; Zhao J; He J; Wu L; Yang J; Zheng Y
    J Neurochem; 2021 Jul; 158(2):444-454. PubMed ID: 33694231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KAP, the accessory subunit of kinesin-2, binds the predicted coiled-coil stalk of the motor subunits.
    Doodhi H; Ghosal D; Krishnamurthy M; Jana SC; Shamala D; Bhaduri A; Sowdhamini R; Ray K
    Biochemistry; 2009 Mar; 48(10):2248-60. PubMed ID: 19161286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
    Regitz C; Dußling LM; Wenzel U
    Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP.
    Kamal A; Almenar-Queralt A; LeBlanc JF; Roberts EA; Goldstein LS
    Nature; 2001 Dec; 414(6864):643-8. PubMed ID: 11740561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1.
    Matsuda S; Matsuda Y; D'Adamio L
    J Biol Chem; 2003 Oct; 278(40):38601-6. PubMed ID: 12893827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ42 and Aβ40: similarities and differences.
    Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
    J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint.
    Rudinskiy N; Fuerer C; Demurtas D; Zamorano S; De Piano C; Herrmann AG; Spires-Jones TL; Oeckl P; Otto M; Frosch MP; Moniatte M; Hyman BT; Schmid AW
    Alzheimers Dement; 2016 Sep; 12(9):996-1013. PubMed ID: 27130892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of β-amyloid peptide self-assembly and cytotoxicity by poly(LVFF-co-β-amino ester).
    Xie H; Qiao Z; Wang H; Duan H; Yang Y; Wang C
    J Pept Sci; 2015 Jul; 21(7):608-14. PubMed ID: 25931322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10.
    Aitken L; Quinn SD; Perez-Gonzalez C; Samuel ID; Penedo JC; Gunn-Moore FJ
    Chembiochem; 2016 Jun; 17(11):1029-37. PubMed ID: 26991863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent and luminescent fusion proteins for analyses of amyloid beta peptide aggregation.
    Usui K; Mie M; Andou T; Mihara H; Kobatake E
    J Pept Sci; 2017 Jul; 23(7-8):659-665. PubMed ID: 28378376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of new fusion proteins for visualizing amyloid-β oligomers in vivo.
    Ochiishi T; Doi M; Yamasaki K; Hirose K; Kitamura A; Urabe T; Hattori N; Kinjo M; Ebihara T; Shimura H
    Sci Rep; 2016 Mar; 6():22712. PubMed ID: 26982553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.